Log In
BCIQ
Print this Print this
 

Lexiva, Telzir, fosamprenavir calcium

Also known as: GW433908, VX-175

  Manage Alerts
Collapse Summary General Information
Company Vertex Pharmaceuticals Inc.
DescriptionProdrug of amprenavir HIV protease inhibitor
Molecular Target HIV protease
Mechanism of ActionViral protease inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV infection; Treat HIV infection in combination with other antiretroviral agents; Treat HIV infection in patients co-infected with hepatitis B virus (HBV) or hepatitis C virus (HCV); Treat HIV infection in treatment-experienced patients; Treat HIV infection in treatment-experienced patients with prior virologic failure; Treat HIV infection in treatment-naïve patients
Regulatory Designation
PartnerViiV Healthcare Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today